Trademark Attorney / Law Firm
Michael A. Antista – Trademark Portfolio
Michael A. Antista specializes in Class 5 (Pharmaceuticals) trademark filings before the United States Patent and Trademark Office (USPTO), with 9 of 18 total filings concentrated in this category. The practice also covers Class 3 (Cosmetics & Cleaning) along with 9 other Nice Classification classes. Filing activity spans from 2008 to 2011. Currently, 0 trademarks are registered.
Showing of trademarks Trademarks
Practice Areas by Trademark Class
Michael A. Antista's trademark practice covers 9 Nice Classification classes, representing the range of industries and goods/services handled in their USPTO filings.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Leather and imitations of leather; animal skins, hides; trunks and travelling bags
Frequently Asked Questions
How many trademark applications has Michael A. Antista filed?
Michael A. Antista has filed 18 trademark applications with the United States Patent and Trademark Office (USPTO).
What trademark classes does Michael A. Antista specialize in?
Michael A. Antista has filed trademarks across 9 Nice Classification classes. The most common practice areas include Class 5 (Pharmaceuticals), Class 3 (Cosmetics & Cleaning), Class 10 (Medical Apparatus), Class 21 (Housewares), Class 24 (Fabrics). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
How long has Michael A. Antista been filing trademarks?
Michael A. Antista's trademark filing history with the USPTO spans from 2008 to 2011, covering 3 years of trademark practice. During this period, Michael A. Antista has handled 18 trademark applications.
What is Michael A. Antista's trademark registration success rate?
Michael A. Antista has a 0% trademark registration rate, with 0 out of 18 resolved applications resulting in successful registration. Currently, 0 applications are pending review.